Parenteral Manual


Disclaimer: Official controlled document is the CHEO online copy. It is the responsibility of user to ensure that any paper copy version is the same as the online version before use.

Alternate Name(s): 
Bronchodilator; B2-Adrenergic agonist
Original Date: 
August 2005
Revised Date: 
June 2017
  • For the relief of severe bronchospasm in acute asthma                    
  • Treatment of status asthmaticus
Reconstitution and Stability: 
  • Available as a 1 mg/mL (1000 mcg/mL) solution - 5 mL ampoules               
  • Protect from light
  • Stable at room temperature
  • Diluted solutions stable 24 hours at room temperature

- Solutions Compatible: D5W, 0.9% NS, dextrose-saline combinations, Sterile Water for Injection

- Y-site Compatible: morphine

- NO INFORMATION on compatibility with KCl or TPN


(For approved routes of administration by nursing personnel, refer to Policy for the Administration of Intravenous Medications.)

IV Direct


IV Intermittent Infusion NO
IV Continuous Infusion

YES,  NOT recommended except in PICU
Usual dilution: 0.5 mg/mL

Click  here to access SDC Drug Infusion Sheet


(For neonatal dosages, refer to Neonatal IV Drug Manual.)


  • 1 mcg/kg/minute; increase by 1 mcg/kg/minute Q 10-20 minutes PRN
  • Maximum: 10 mcg/kg/minute


  • continuous IV infusion:  5 mcg/minute initially, increase if required to 10 mcg/minute and 20 mcg/minute at 15 - 30 minutes interval. 
  • Maximum:  50 mcg/minute; doses as high as 80 mcg may be required
Potential hazards of parenteral administration: 
  • May cause tremor, nervousness, headache, nausea, dizziness, increased sweating, warmth, tachycardia, mild hypotension
  • Hypokalemia, hyperglycemia
  • Monitor heart rate, respiratory rate, serum potassium, serum glucose
  • Signs of overdose include: severe tachycardia, arrhythmias, hypertension

The information contained on this website is provided for informational purposes only, as a guide to assist physicians, nurses and other healthcare providers in deciding on the appropriate care required for a particular patient. At all times, physicians, nurses and other healthcare providers must exercise their independent clinical judgment, based on their knowledge, training and experience, taking into account the specific facts and circumstances of each patient, when deciding on the appropriate course of investigation and/or treatment to recommend in a particular clinical situation.

CHEO has made every effort to ensure that the information contained on this website is as current and accurate as possible. However, changes can occur due to ongoing research and the constant influx of new information. Where possible, hospitals and healthcare practitioners should verify the information before acting on it.

Reliance on any information in this website is at the user's own risk. CHEO is not responsible or liable for any harm, loss or other consequences from the use or misuse of the information on this website.